Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_assertion type Assertion NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_head.
- NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_assertion description "[IGRP inhibitors may be an attractive new approach for the treatment of insulin secretion defects in type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_provenance.
- NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_assertion evidence source_evidence_literature NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_provenance.
- NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_assertion SIO_000772 14722102 NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_provenance.
- NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_assertion wasDerivedFrom befree-20150227 NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_provenance.
- NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_assertion wasGeneratedBy ECO_0000203 NP933753.RALmjyQQfdJcMxT7jfkoeo_7E40ETWzR2fxD1X2xfHa5U130_provenance.